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A B S T R A C T
In order to study the renal function, in terms of glomerular filtration and effective renal plasma flow, in broiler
chickens and pigs, an ultra-high performance liquid chromatography–tandem mass spectrometry method for the
simultaneous determination of iohexol, p-aminohippuric acid (PAH) and exogenously administered creatinine in
plasma was developed and validated. Sample preparation consisted of a deproteinization step using methanol for
porcine plasma and an Ostro™ Protein Precipitation & Phospholipid Removal Plate was used for broiler chicken
plasma. Chromatographic separation was achieved on a Hypersil Gold aQ column using 0.1% formic acid in
water and 0.1% formic acid in methanol as mobile phases. The total run time was limited to 10min. Matrix-
matched calibration curves for iohexol and PAH were prepared and good linearity (r≥ 0.9973; gof≤ 6.17%)
was achieved over the concentration range tested (0.25–90 μg/mL). Limits of quantification were 0.25 μg/mL for
iohexol and PAH. Water was used as surrogate matrix for analysis of creatinine in plasma. This surrogate ca-
libration curve showed good linearity over the concentration range tested (0.25–90 μg/mL) (r≥ 0.9979;
gof≤ 5.66%). For creatinine, the relative lower limit of quantification was 201.03 ± 49.20% and
60.14 ± 7.64% for chicken and porcine plasma, respectively. The results for within-day and between-day
precision and accuracy fell within the specified ranges.
This straightforward, cost-effective and rapid method, determining iohexol, PAH and creatinine within one
single chromatographic run, has been successfully used for the analysis in porcine and broiler chicken plasma
samples in order to determine the renal function of these species.
1. Introduction
The kidneys play a crucial role in the elimination of various en-
dogenous as well as exogenous compounds. Since pharmaceuticals are
often eliminated by the kidney, assessment of the renal function is
necessary to assure appropriate drug exposure. Especially since this
excretory function can be significantly altered in case of illness. In order
to assess renal function, accurate measurement of the glomerular fil-
tration rate (GFR) and effective renal plasma flow (ERPF) are essential.
The GFR is currently considered as the best quantitative parameter
of the overall kidney function. It can be measured with several
endogenous and exogenous filtration markers, such as inulin, creati-
nine, iohexol, cystatin C and chromium51-labelled ethylene diamine
tetra acetic acid [1]. Inulin is still considered as the major reference
substance for GFR determination, but is not regarded practical for
routine clinical purposes since it requires constant rate infusion, urinary
bladder catheterization and is expensive and laborious to use [2–4].
Therefore, in clinical practice, GFR is often estimated from the serum
concentrations of endogenous creatinine. However, determination of
this marker has multiple confounding factors such as body composition,
age, dietary intake and chronic illness [1]. Furthermore, GFR de-
termined by creatinine clearance is often overestimated because
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creatinine is, besides glomerular filtrated, also partially tubular se-
creted [5].
A promising marker for GFR determination is iohexol, a radiological
contrast medium. It is not bound to plasma proteins, freely filtered by
the kidneys, does not undergo tubular secretion nor reabsorption and
has a low extra-renal excretion. Furthermore, it is virtually non-toxic
and has a low cost. Due to these properties, iohexol comes very close to
fulfilling all requirements for an ideal GFR marker [6]. Hence, it is
increasingly accepted as a marker for GFR determination and applied
by clinicians and researchers in both human and veterinary medicine.
Another alternative for GFR measurements is the plasma clearance of
intravenously administered exogenous creatinine, also known as the
plasma exogenous creatinine clearance test (PECCT) [7,8]. In healthy
dogs and dogs with a 60% decrease in GFR, it was demonstrated that
the PECCT is an accurate indicator of GFR [7]. In the study of van Hoek
et al. a statistically significant difference in GFR value was observed
between the GFR calculated as iohexol and creatinine clearance in
hyperthyroid cats before and after treatment with radioiodine. Not-
withstanding these results, these different GFR methods correlated with
each other [8]. To the authors' knowledge, PECCT was not performed
yet in other animal species such as pigs and broiler chickens. Especially
pigs are an interesting species because of their value in biomedical
research as animal model for humans [9,10]. Therefore, further re-
search is necessary to investigate if the PECCT is a reliable method for
the GFR determination in broiler chickens and pigs.
The clearance of p-aminohippuric acid (PAH) is considered to be the
gold standard for the assessment of ERPF. This compound is freely fil-
tered through the glomerulus, undergoes extensive tubular secretion
and negligible reabsorption. At low levels, the compound is almost
completely cleared from plasma as it passes through the kidney.
Generally, concentrations lower than 30mg/L are recommended in
humans to minimize the chances of saturating tubular secretion [5,11].
Very divergent analytical methods have been developed to measure
creatinine, iohexol and PAH separately in human and/or animal
plasma. The most widely used techniques to assess creatinine levels are
high-performance liquid chromatography with ultraviolet (LC-UV) or
mass spectrometric detection (LC-MS), enzymatic assays and the alka-
line picrate method [12–15]. The latter, which is also known as the
Jaffe method, is currently the most widely used technique in clinical
practice. However, the main disadvantage of this technique is its low
specificity [16].
An important hampering factor in the quantitative determination of
exogenous creatinine using chromatographic techniques is the en-
dogenous presence of this compound in biological samples and the
difficulty to obtain creatinine-free samples of the authentic biological
matrix [17,18]. The lack of this analyte-free plasma matrix implies that
alternative strategies for calibration have to be followed in contrast to
xenobiotics. Currently, the validation principles for quantification of
xenobiotics using chromatographic techniques are well established and
reported in guidelines and other literature. In contrast, official guide-
lines for the validation of chromatographic methods for the quantitative
determination of endobiotics, which are exogenously administered
substances that are also endogenous present, are lacking, especially for
parameters such as accuracy and limit of quantification (LOQ) [17–19].
As a result, erroneous conclusions are often drawn about the validity of
the method.
To quantify iohexol or PAH in plasma, most published methods use
liquid chromatography combined with ultraviolet or mass spectro-
metric detection [20–23]. The limited number of studies that describe
the simultaneous quantification of iohexol and PAH all used the LC-UV
technique. These methods are characterized by long chromatographic
run times (≥18min) and relatively high LOQ values, ranging from 2 to
10 μg/mL and 0.5–5.0 μg/mL for iohexol and PAH, respectively
[24–26]. To date, no sensitive methods have been reported for the si-
multaneous determination of iohexol, PAH and exogenously adminis-
tered creatinine in plasma. In order to analyse a high number of
samples, a high throughput sample preparation and short chromato-
graphic run are mandatory. Therefore, LC-MS/MS is the preferred
method since MS-detection is generally considered as more selective
and specific than UV-detection. Consequently, sample clean-up is often
simplified and shorter chromatographic times can be achieved [23].
The aim of this study was to develop and validate a sensitive and
specific ultra-high performance liquid chromatography–tandem mass
spectrometry (UHPLC-MS/MS) method for the quantitative, simulta-
neous determination of iohexol, PAH and exogenously administered
creatinine in porcine and broiler chicken plasma. The analysis of these
three compounds within one single chromatographic run makes it
possible to determine the EPRF and GFR at the same time, the latter
parameter by two different methods. In that way the reliability of the
PECCT test and its correlation with GFR, calculated as the iohexol
clearance, can be determined in chickens and pigs. During the valida-
tion, special attention was given to the validation of creatinine, which is
also endogenously present. Furthermore, this method can be used to
evaluate the effect of several (induced-)disease states, like lipopoly-
saccharides (LPS)-induced sepsis, on the excretory renal function. The
applicability of the method was shown by analysis of samples of a
healthy pig, which were collected as a part of a pilot study determining
the effect of continuous LPS infusion on the renal function. Moreover,
broiler chicken samples were also analysed in order to determine the
ERPF and GFR in broiler chickens.
2. Material and methods
2.1. Chemical, products and reagents
The analytical standards of iohexol, PAH and creatinine hydro-
chloride, as well as the PAH internal standard (IS) para-aminobenzoic
acid (PABA), were purchased from Sigma-Aldrich (Bornem, Belgium)
and were stored at room temperature, except for iohexol, which was
stored at 2–8 °C. The isotopically labelled IS iohexol-d5 and creatinine-
d3 were obtained from Alsachim (Illkirch Graffenstaden, France) and
Cayman Chemicals (Michigan, USA), respectively. Both labelled IS were
stored at ≤−15 °C. For the analytical experiments, stock solutions (SS)
of iohexol and PAH and their respective IS were prepared in methanol,
whereas SS of creatinine and creatinine-d3 were prepared in ultrapure
water. Mixed working solutions (WS) were prepared separately for the
standards and the IS by appropriate dilution of the SS with water. SS
were stored at ≤−15 °C, whereas WS were stored at 2–8 °C. Methanol
(MeOH) and acetonitrile (ACN) were both of LC-MS grade and acquired
from Biosolve (Valkenswaard, The Netherlands). A Milli-Q SP Reagent
water system (Merck Millipore, Darmstadt, Germany) was used to ob-
tain ultrapure (UP) water. Formic acid (FA) was of analytical grade and
purchased from VWR (Leuven, Belgium). Oasis® Ostro™ protein pre-
cipitation and phospholipid removal 96-well plates were obtained from
Waters (Zellik, Belgium). Microfilters, Millex®-GV PVDF (0.22 μm), to
filter the extracted samples were procured from Merck-Millipore
(Overijse, Belgium).
2.2. UHPLC-MS/MS instrumentation
The UHPLC system consisted of a binary pump with vacuum de-
gassing, type Acquity UPLC system, and an autosampler with tem-
perature controlled tray and column oven all from Waters (Zellik,
Belgium). Chromatographic separation was achieved on a Hypersil
Gold aQ column (1.9 μm, 100×2.1mm) protected by a UHPLC filter
(0.2 μm, 2.1 mm ID) (ThermoFisher Scientific, Waltham, Massachusetts,
United States). Gradient elution was established with a mobile phase
consisting of 0.1% (v/v) FA in H2O (eluent A) and 0.1% (v/v) FA in
MeOH (eluent B) at a flow rate of 0.3mL/min. Following gradient
program was run: 0.0–3.0min (100% A, 0% B), 3.0–4.0min (linear
gradient to 60% B), 4.0–5.0min (40% A, 60% B), 5.0–5.1min (linear
gradient to 95% B), 5.1–7.4 min (5% A, 95% B), 7.4–7.5 (linear
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gradient to 100% A), 7.5–10.0 min (100% A, 0% B). Column and au-
tosampler temperature were set at 30 °C and 10 °C, respectively.
The UHPLC column effluent was interfaced to a Quattro Premier XE
triple quadrupole mass spectrometer (Waters) equipped with an elec-
trospray ionization (ESI) probe operating in the positive ionization
mode. The following parameters were obtained after tuning the com-
pound as described in Section 3.1.1: capillary voltage: 3.5 kV, source
temperature: 120 °C, desolvation temperature: 450 °C, desolvation gas
flow: 750 L/h, cone gas flow: 20 L/h and collision gas flow: 6mL/h.
MS/MS acquisition was performed in the multiple reaction monitoring
(MRM) mode. The MRM transitions of the analytes and their IS are
shown in Table 1. Masslynx software 4.1 (Waters Corp., Milford, MA,
USA) was used for data acquisition and processing.
2.3. Biological samples
Blank plasma, used to prepare matrix-matched calibrators and
quality control samples (QC), were obtained from pigs and broiler
chickens that were not treated with the above mentioned renal markers.
This plasma was stored at ≤−15 °C until used for analysis. The ap-
plicability of the method was shown by analysis of plasma samples of
one healthy pig (Belgian landrace× Large white, Seghers Hybrid®,
Wuustwezel, Belgium) which received a single intravenous (IV) dose of
the three renal markers (iohexol (64.7mg/kg body weight (BW), as
Omnipaque 300® (GE Healthcare, Eindhoven, The Netherlands)), PAH
(10mg/kg BW), creatinine (40mg/kg BW)) through a double-lumen
catheter surgically placed in the jugular vein. Doses of these renal
markers were selected based on available literature, using the same
markers in other animal species, like dogs and cats [7,8,25,27]. The
commercially available powders of creatinine hydrochloride and PAH
sodium salt, both purchased from Sigma-Aldrich (Bornem, Belgium),
were dissolved prior to administration in sterile physiological isotonic
NaCl 0.9% solution at a final concentration of 0.14 g/mL creatinine and
0.035 g/mL PAH. Two broiler chickens (Ross 308, Gallus gallus, com-
mercial farm) were also treated. One animal received both iohexol
(64.7 mg/kg BW) and PAH (10mg/kg BW) and the other bird received
both creatinine (40mg/kg BW) and iohexol (64.7 mg/kg BW) in-
travenously in the vena cutanea ulnaris superficialis (wing vein) with a
25-gauge IV catheter. Repetitive blood sampling from the vena meta-
tarsalis plantaris superficialis (leg vein, chicken) or jugular vein, using
the catheter, (pig) was performed after the IV dosing in order to eval-
uate the GFR and ERPF. Blood samples were collected into K3EDTA
(pig) or heparin (chicken) collection tubes (Vacutest®, Piove die Sacco,
Kima, Italy) at 0, 5, 15, 30, and 60min, and at 2, 3, 6, 8 and 12 h after
administration. Additional blood collection was performed 45min and
10 h after administration in case of pig and chicken, respectively. After
sampling, all blood samples were centrifuged at 2851×g for 10min at
4 °C. Plasma was stored at ≤−15 °C until analysis. To calculate the GFR
and ERPF, plasma concentration-time profiles of iohexol, PAH and
exogenous creatinine were plotted. The exogenous creatinine plasma
concentrations were calculated by subtracting basal creatinine plasma
concentration, measured before the administration of the renal mar-
kers, from the total creatinine plasma concentration at the different
time points after administration. Thereafter, total body clearances of
the renal markers were calculated by non-compartmental pharmaco-
kinetic analysis. Hereby, the area under the curve (AUC0➔inf) of the
plasma concentration-time profiles was determined using the trape-
zoidal rule with extrapolation to infinity. Subsequently clearances were
calculated by dividing the administered dose by the AUC0➔inf.
The animal experiments were approved by the Ethical Committee of
the Faculty of Veterinary Medicine and the Faculty of Bioscience
Engineering of Ghent University (approval numbers EC2017/24,
EC2015/155 & EC2017/58).
2.4. Sample preparation
Porcine plasma samples were prepared as follows: 100 μL of plasma
was spiked with 50 μL of ultrapure water and 25 μL of IS WS, consisting
of creatinine-d3 (20 μg/mL), iohexol-d5 (50 μg/mL) and PABA (5 μg/
mL), followed by vortex mixing (10 s). Thereafter, sample proteins were
precipitated with 1mL of MeOH, followed by vortex mixing (10 s) and a
centrifugation step (15min, 7825×g). The supernatant was transferred
to another tube and evaporated under a gentle N2 stream (40 ± 5 °C).
Next, the dry residue was reconstituted in 250 μL of UP water and
vortex mixed thoroughly for 15 s. The samples were filtered through a
Millex®-GV PVDF (0.22 μm) syringe filter and transferred into an au-
tosampler vial. A 1.0-μL aliquot was injected onto the LC-MS/MS in-
strument.
For chicken plasma, 50 μL of ultrapure water and 25 μL of IS WS,
consisting of creatinine-d3 (5 μg/mL), iohexol-d5 (50 μg/mL) and PABA
(5 μg/mL) were added to 100 μL of plasma, followed by vortex mixing
and application onto an Ostro™ 96-well plate. Subsequently, 300 μL of a
1% formic acid in ACN solution were added and the samples were as-
pirated three times using a multi-channel pipette. Vacuum (15mmHg)
was applied for 10min to pass the samples through the 96-well plate.
The individual samples were transferred to a glass tube and evaporated
to dryness under a gentle N2 stream (40 ± 5 °C). Further sample pre-
paration was analogous to that of porcine plasma. A 10-μL aliquot was
injected onto the LC-MS/MS instrument.
2.5. Extraction recovery (RE) and signal suppression and enhancement
(SSE)
To assess RE and SSE, three batches of samples (n= 3), each spiked
at two concentration levels (2.5 and 50 μg/mL), were prepared. The
first batch (B1) consisted of matrix-matched samples prepared by
spiking blank matrix before the extraction procedure. Batch two (B2)
was prepared in the same way as B1, but the blank extracts were spiked
after the extraction procedure. Batch three (B3) consisted of a standard
solution of the analyte in the reconstitution solvent. RE and SSE were
determined by dividing the peak areas of the analytes of interest in the
samples of the different batches, using the following formulas:
SSE B
B
(%) 1002
3
= ×
R B
B
(%) 100E 1
2
= ×
Since the level of an endogenous analyte, such as creatinine, in an
unspiked sample is unknown, it was impossible to directly establish SSE
and RE in authentic matrix. Alternatively, these parameters were de-
termined by a surrogate compound in authentic matrix. In this case, the
isotopically labelled internal standard creatinine-d3 was used for as-
sessing the SSE and RE of creatinine.
Table 1
Liquid chromatography-tandem mass spectrometric parameters for the analysis
of iohexol, para-aminohippuric acid (PAH) and creatinine and their respective
internal standards (iohexol-d5, para-aminobenzoic acid (PABA) and creatinine-
d3) in porcine and broiler chicken plasma.
Analyte Retention
time (min)
Precursor
ion (m/z)
Cone
voltage
(V)
Product ions (m/z)
(collision energy (eV))
Quantifier Qualifier
Iohexol 4.53 822.0 40 804.0 (25) 731.2 (20)
Iohexol-d5 4.53 827.0 40 809.0 (25) 736.1 (20)
PAH 3.36 195.1 15 119.9 (10) 91.9 (30)
PABA 4.67 137.8 30 77.2 (20) 65.1 (30)
Creatinine 0.96 113.8 30 44.1 (15) 86.0 (10)
Creatinine-d3 0.96 117.2 30 47.4 (15) 89.4 (10)
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2.6. Method validation
The performance characteristics of both methods for the analysis of
pig and broiler chicken plasma were checked by a set of parameters that
were in accordance to recommendations reported in literature, inter-
national guidelines and recommendations defined by the European
Commission [28–32]. Following parameters were used to evaluate
method performance: linearity, within-day and between-day accuracy
and precision, limit of quantification (LOQ), limit of detection (LOD),
carry-over and specificity. Special attention was given to the validation
of the endogenously present compound, creatinine.
2.6.1. Linearity
For iohexol and PAH, linearity of three matrix-matched calibration
curves (0.25–90 μg/mL) was evaluated on three different analysis days
using the correlation coefficient (r) and goodness-of-fit coefficient (gof).
Acceptance criteria were ≥0.99 and ≤10% for r and gof, respectively.
Since no analyte-free plasma is available for the analysis of creatinine,
UP water was used as surrogate matrix. To evaluate the optimal
weighing factor, the gof factors of three calibration curves were
summed up per weighting factor. The weighting factor that resulted in
the smallest sum of gof values was considered most appropriate.
2.6.2. Accuracy and precision
For iohexol, PAH and creatinine, within-day accuracy and precision
were evaluated by analysing on the same day each time six blank
samples spiked at three different concentration levels: 1 (low), 10
(medium) and 75 (high) μg/mL. The between-day precision and accu-
racy were determined by analysing each time three quality control (QC)
samples at the before mentioned concentration levels, run on three
different days (n=3×3). Additionally, within-day (n=6) and be-
tween-day (n= 3×3) accuracy and precision of creatinine in the
surrogate matrix, water, undergoing the same extraction procedure as
the plasma samples was determined.
In case of iohexol and PAH, the acceptance criteria for accuracy
were −20% to +10% for all concentration levels. Within-day and
between-day precision acceptance were evaluated by calculating the
relative standard deviation (RSD, %). The RSD value had to be below
10% for within-day precision and below the RSDmax value, which was
calculated as 2(1−0.5log·C) with C the concentration of analyte expressed
in g/mL, for between-day precision.
The accuracy of the method for creatinine in pig or broiler chicken
plasma was evaluated according to Tsikas et al. [17]. The accuracy
(expressed as %) was calculated according to the formula:
Accuracy C C
C
1 100M basal= ×+
with CM being the analyte concentration measured in the biological
sample, whereas Cbasal is the basal concentration of the endogenous
compound in the blank, not spiked sample and C+ is the known nom-
inal exogenous concentration of the analyte that was added to the
sample. The precision of the analytical method was expressed as the
RSD. The same acceptance criteria for precision and accuracy were
applied as for iohexol and PAH.
Since iohexol plasma concentrations above the upper limit of
quantification were observed for the first sampling points, the effect of
dilution of the final extracts of samples was investigated. Therefore, the
extracts of the QCs at 75 μg/mL were diluted 4-fold with UP water
(n=3×2). With this dilution factor, the peak area of the IS was still
high enough to be integrated accurately. To calculate the concentra-
tion, the peak area of the internal standard was multiplied with the
dilution factor, after which the ratio analyte area/IS area was calcu-
lated. In this way, this ratio could be used to establish the concentration
level in the diluted samples. To obtain the actual plasma concentration
level, the concentration measured was multiplied by the dilution factor.
The same acceptance criteria for precision and accuracy were applied as
mentioned above.
2.6.3. LOQ, rLLOQ, LOD, carry-over and specificity
For iohexol and PAH the lowest concentration that could be quan-
tified with an accuracy and precision that fell within the recommended
ranges (see section accuracy and precision) was considered as LOQ.
Furthermore, the LOQ was the lowest point of the calibration curve.
The LOQ was determined by analysing six spiked samples on the same
day. For creatinine, the LOQ was considered to be the lowest spiked
analyte concentration that could be measured with an acceptable ac-
curacy and precision. It was also important that this concentration
could be distinguished from the basal/endogenous concentration of the
analyte in matrix. Since the basal concentration could vary between
different biological samples, the relative lower limit of quantification
(rLLOQ) was used to characterize the analytical performance [17]. This
was calculated as follows:
rLLOQ
C
C
100LOQ
basal
= ×
with CLOQ the lowest spiked analyte concentration that could be mea-
sured with acceptable accuracy and precision and Cbasal the basal/en-
dogenous concentration of the analyte in the matrix. The acceptance
criteria for the rLLOQ are the same as mentioned in the section accu-
racy and precision.
The LOD of iohexol and PAH was defined as the lowest concentra-
tion that could be determined with a signal-to-noise (S/N) ratio of ≥3.
The LOD was determined by calculating the analyte concentration that
corresponds with a S/N ratio of 3/1 based on the S/N ratio of the
qualification ion of the analyte in six LOQ samples. Assessment of the
LOD for creatinine in plasma is not useful due to the relatively high
endogenous plasma levels of creatinine in chicken and porcine plasma.
Carry-over was evaluated by injecting a water sample after the
highest calibrator sample. If a peak was detected at the elution zone of
the analytes of interest, the concentration had to be below the LOD.
To evaluate the specificity of the method, a blank sample was
analysed. The S/N ratio of a possible interfering peak may not exceed
the S/N ratio of the analyte(s) in the same elution zone at LOD level.
Obviously, the evaluation of the specificity of the method with respect
to creatinine was impossible due to the absence of analyte-free matrix.
3. Results and discussion
3.1. Optimization of the LC-MS/MS conditions
3.1.1. Mass spectrometry
Tuning of the MS/MS parameters was performed by direct infusion
of a 1 μg/mL solution into the ion source at an infusion rate of 20 μL/
min. Analyte responses in both ESI+ and ESI− mode were evaluated.
The positive ionization mode was chosen based on the highest intensity
of the precursor ion peak, which corresponded with the pseudo mole-
cular ion [M+H]+ for all compounds. After optimization of the MS
instrument parameters, the protonated molecular ions were fragmented
and cone voltages and collision energies (CE) were optimized. The most
abundant product ion was chosen as the quantifier ion, while the
second most intense product ion was selected as qualifier ion. The ion
ratio, which is the relative abundance of quantifier ion/qualifier ion,
was used to assure the right compound was determined in the samples.
The permitted tolerance for the deviation of the ion ratio was set
at± 20%,±25%,±30% and±50% for relative abundances
of> 50%, 20–50%, 10–20% and ≤10% respectively. The reference
relative abundances were based on the ion ratios of the analytes of
interest in the calibration curve samples that were run with each batch
of samples. The MRM transitions, with their respective CE and cone
voltages are listed in Table 1. The precursor and product ions of
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creatinine, PAH, iohexol and PABA were in accordance with other lit-
erature reports [22,23,33–35].
3.1.2. Chromatography
In literature, chromatographic separation of iohexol, PAH or crea-
tinine was performed using a wide range of column types due to the
divergent molecular structure and physico-chemical properties of these
renal makers (Fig. 1). For the chromatographic separation of creatinine,
the use of different kinds of hydrophilic interaction liquid chromato-
graphy (HILIC) [34,36], normal phase [37] as well as reversed phase
columns [35,38] were reported. In general, chromatography of iohexol
is accomplished using reversed phase columns [20,23,24]. A few io-
hexol methods mention the separation of the isomers of iohexol, endo-
iohexol and exo-iohexol. However, since no differences are observed in
clearance of both isomers in birds and pigs, separation of these isomers
is of limited added value for the purpose of GFR assessment and it could
impair sensitivity, run time and/or sample throughput (Unpublished
results). For PAH analysis, reversed phase and HILIC columns are
commonly applied in literature [22,39,40]. Since reversed phase col-
umns are the common factor for the chromatographic separation of all
three compounds, different types of these columns (Acquity BEH C18,
50×2.1mm i.d., dp: 1.7 μm, Waters; Acquity HSS-T3, 100×2.1mm
i.d., dp: 1.8 μm, Waters; PLRP-S, 150×2.1mm i.d., dp: 5.0 μm, Agi-
lent; Hypersil gold, 50× 2.1mm i.d., dp: 1.9 μm, Thermo Scientific;
Hypersil gold aQ, 100×2.1mm i.d., dp: 1.9 μm, Thermo Scientific)
were evaluated. The major challenges encountered during method de-
velopment was the retention and peak shape of PAH and creatinine on
reversed phase columns. Several mobile phases (H2O, ACN and MeOH
alone and in combination with ammonium hydroxide, FA, tri-
fluoroacetic acid or ammonium acetate) and gradient programs were
evaluated. The best results were obtained using a Hypersil gold aQ
column using H2O and MeOH, both containing 0.1% FA as mobile
phase A and B. Retention times of all compound and a representative
chromatogram can be found in Table 1 and Fig. 2c. The total run time
was only 10min, which is considerably shorter than other methods
determining iohexol and PAH simultaneously, ranging from 20 to
30min [24–26]. Besides, it is the first analytical method where the
three renal makers, creatinine, iohexol and PAH, are determined within
one single chromatographic run.
3.2. Optimization of the sample clean-up
The preferred extraction method for the determination of iohexol, PAH
and creatinine in plasma and serum samples is a simple deproteinization
using acid or an organic solvent. Since it is straightforward and less time
consuming than liquid-liquid and solid-phase extraction, it is an ideal high-
throughput method to analyse a high number of samples per day, which is
the case in pharmacokinetic studies. Hence, clean-up by protein pre-
cipitation was the method of choice. During method development several
Fig. 1. Molecular structure of iohexol (a), para-aminohippuric acid (b) and creatinine (c).
Fig. 2. LC–MS/MS chromatograms of creatinine (RT: 0.96min), para-amino-
hippuric acid (PAH) (RT:3.36min) and iohexol (RT: 4.53min) in a blank broiler
chicken plasma sample (a), blank pig sample (b) and an incurred sample from a
pig after intravenous administration of a bolus of iohexol (64.4 mg/kg), PAH
(10mg/kg) and creatinine (40mg/kg) (c).
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protein precipitation agents were evaluated. The use of organic acids, such
as trifluoroacetic acid and trichloroacetic acid led to a drop-down in signal
for PAH, indicating the instability of this compound in acidic environment.
Deproteinization with MeOH seemed to be slightly better than ACN, re-
garding the visual purity of the supernatant after centrifugation of the
samples. Since protein precipitation with MeOH, followed by direct in-
jection of an aliquot of the supernatant onto the UHPLC-MS/MS instru-
ment led to a distorted peak shape of PAH (fronting), evaporation of the
supernatant and constitutive reconstitution in 100% water was necessary
to guarantee appropriate peak shape. This method was promising for the
analysis of the three renal markers in pig plasma, with extraction re-
coveries between 90 and 100% (Table 2). However, a simple protein
precipitation step seemed insufficient in case of chicken plasma, since
clogging of the tubings of the UHPLC instrument were encountered during
analysis. This could probably be attributed to the on-going precipitation of
plasma proteins and to the high amount of phospholipids present in
chicken plasma [41]. As an alternative, a generic sample preparation
procedure, based on protein precipitation using 1% FA in ACN in com-
bination with phospholipid removal, using Ostro™ 96-well plates, was
tested. Acceptable extraction recoveries for iohexol and creatinine were
obtained (Table 2). However, RE of PAH was limited (RE=20.65%). To
investigate which parameters attributed to this low recovery, different
tests were carried out: the effect of the acidic solution (1% FA in ACN), the
Ostro™ 96-well plates as well as evaporation under gentle nitrogen stream
were investigated. The latter did not affect the recovery of the compounds.
Conversely, incubation of a standard solution of the renal markers with 1%
FA in ACN, followed by evaporation led to a decrease in recovery of about
25%. In contrast, a limited effect of direct interaction of PAH with the
plate was detected, suggesting that RE of PAH is further declined as a result
of adherence of PAH to the pellet or interaction with the phospholipids on
the Ostro™ plate. Notwithstanding, the Ostro™ plate was selected as
sample purification method for chicken plasma, since this method resulted
in cleaner samples with respect to phospholipids and acceptable precision
and accuracy values were reached (Table 4). This could probably be at-
tributed to the good compensation capacity of the IS, PABA, which has a
similar recovery as PAH (RE=17.91 ± 4.50%). Furthermore, the poor
recovery did not affect the LOQ since an LOQ of 0.25 μg/mL could be
reached as reported in Section 3.4.3.
3.3. Evaluation of SSE
Analyte quantification can be strongly affected by matrix effects
when using LC-MS/MS. This is caused by co-eluting matrix compo-
nents, which affect the ionization efficiency of the analyte. The ioni-
zation of the latter can either be enhanced or suppressed. For iohexol
and PAH, the observed SSE in porcine and broiler chicken plasma were
limited and fell within 90 and 105%. Details of matrix effects are
summarized in Table 2.
In case of pig plasma the signal of creatinine-d3 was reduced with
approximately 50%, whereas the signal in chicken plasma was declined
to about 20%. These findings are probably partially attributed to the
limited retention of creatinine (RT= 0.96min) on the column.
Somewhat surprising is the fact that more matrix-effects are observed in
case of chicken plasma in comparison to pig plasma, since the sample
preparation of chicken plasma (Ostro® 96-well plate) is more elaborate
than the simple deproteinization of pig plasma. However, this ob-
servation confirms the complexity of chicken plasma. To minimize the
influence of these matrix-effects the isotopically labelled IS, creatinine-
d3, which possesses identical structural and physico-chemical proper-
ties as creatinine, was used. Generally, the use of a stable isotope-la-
belled IS can satisfyingly compensate matrix effects due to co-elution
with the compound of interest and therefore it is subjected to the same
matrix effects on the MS/MS instrument [42,43].
3.4. Method validation
3.4.1. Linearity and carry-over
Linear matrix-matched calibration curves, covering a concentration
range of 0.25 to 90 μg/mL, were obtained for iohexol and PAH. Also,
linearity was demonstrated for creatinine in the surrogate matrix,
water. The smallest sum of gof was found for a weighing factor 1 / x2 for
all compounds. Using this factor it was possible to compensate for the
observed heteroscedasticity, which improved accuracy in the lower
concentration range [44]. As shown in Table 3, good correlation be-
tween analyte concentrations and detected responses was demonstrated
for all compounds, with r values ranging between 0.9973 and 0.9991
and gof values between 3.77 and 6.17%.
No carry-over was present as there were no analytes detected in the
solvent sample injected after the highest calibrator.
3.4.2. Accuracy and precision
The results for within- and between-day accuracy and precision
evaluation of iohexol, PAH and creatinine are summarized in Table 4.
Additionally, the results of within- and between-day accuracy and
precision of creatinine in surrogate matrix, water, are presented in
Table S1. As can be seen, the acceptability ranges for accuracy and
precision were met for all compounds at the specified levels. However,
the acceptability ranges for creatinine in pig plasma were not met at a
concentration level of 1 μg/mL using the method recommended by
Tsikas et al. [17]. This is probably attributed to the high endogenous
Table 2
Signal suppression and enhancement (SSE) and extraction recovery (RE) of io-
hexol, para-aminohippuric acid (PAH) and creatinine-d3 in porcine and broiler
chicken plasma.
Analyte Porcine plasma Chicken plasma
SSE (%) RE (%) SSE (%) RE (%)
Iohexol 95.36 ± 7.76 93.80 ± 4.75 90.34 ± 4.14 67.23 ± 2.65
PAH 96.71 ± 4.95 97.07 ± 3.63 104.09 ± 4.78 20.65 ± 4.92
Creatinine-d3 50.92 ± 8.08 92.93 ± 9.26 19.34 ± 7.12 66.45 ± 4.30
Table 3
Results of the evaluation of linearity (goodness-of-fit coefficient (gof), correlation coefficient (r)), limit of detection (LOD), and limit of quantification (LOQ) of
iohexol and para-aminohippuric acid (PAH) in broiler chicken and porcine plasma, and creatinine in water using the extraction procedure for porcine and broiler
chicken plasma.
Analyte Calibration range (μg/
mL)
Porcine plasma Chicken plasma
gofa (%) (n=3) ra (n= 3) LOD (μg/
mL)
LOQ (μg/
mL)
gofa (%) (n= 3) ra (n= 3) LOD (μg/
mL)
LOQ (μg/
mL)
Iohexol 0.25–90 6.16 ± 2.24 0.9973 ± 0.0016 0.084 0.25 6.17 ± 1.43 0.9975 ± 0.0011 0.032 0.25
PAH 0.25–90 3.77 ± 0.63 0.9991 ± 0.0003 0.004 0.25 6.09 ± 0.57 0.9975 ± 0.0005 0.009 0.25
Creatinineb 0.25–90 4.0 ± 1.67 0.9988 ± 0.0010 0.012 0.25 5.66 ± 1.65 0.9979 ± 0.0011 0.014 0.25
a Acceptance criteria: r > 0.99 and gof < 10%.
b Result determined in water using the plasma extraction protocol.
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creatinine levels in pig plasma (mean=7.79 ± 0.90 μg/mL) in com-
parison with chicken plasma (mean= 0.52 ± 0.11 μg/mL). Therefore,
an extra QC level at 5 μg/mL was included for pig plasma. Interesting to
notice is how the two different formula described by Tsikas et al.
yielded different results. The formula used in this paper and described
in the material and methods section is much stricter and according to
Tsikas et al. superior to the formula below, which is used by some other
authors to calculate the accuracy for endogenous substances [17]. If the
formula below was used at a spiked concentration level of 1 μg/mL in
pig plasma, the accuracy did fall within the specified ranges.
Accuracy C
C C
1 100M
basal
= + ×+
Notwithstanding, these results demonstrate that water as a surro-
gate matrix for plasma in combination with the use of an isotopically
labelled IS can be applied for the quantitative determination of exo-
genous administered creatinine in chicken and pig plasma.
The dilution experiment showed that porcine and chicken plasma
can be diluted 4-fold without compromising the accuracy and precision.
The accuracy was −3.0 and 4.1%, and the precision was 4.8 and 6.9%
for porcine and broiler chicken plasma, respectively.
3.4.3. LOQ, rLLOQ, LOD and specificity
Results for LOQ and LOD are summarized in Table 3. With LOQ
values of 0.25 μg/mL for iohexol and PAH in plasma, this method is at
least 2 to 8 times more sensitive compared to other literature reports for
iohexol and PAH [22,26,45]. For creatinine, it was not possible to
calculate an LOQ value due to the presence of a mean basal con-
centration of 7.79 μg/mL and 0.52 μg/mL in porcine and broiler
chicken plasma, respectively. The lowest added exogenous creatinine
concentration, which could be quantified with an acceptable accuracy
and precision, was 5 μg/mL for porcine and 1 μg/mL for broiler chicken
plasma. An alternative parameter taking into account the endogenous,
basal concentration of creatinine is rLLOQ, which was
201.03 ± 49.20% for chicken and 60.14 ± 7.64% for pig plasma,
respectively. These values are higher than reported by Tsikas et al.
(rLLOQ=16%), but are sufficient enough to analyse the last plasma
samples collected after dosing, since an extrapolated area under the
plasma concentration-time curve (AUCt→inf) of< 20% is observed
when pharmacokinetic analysis is performed [17,46]. This extrapolated
area is determined by the slope (reflecting elimination rate constant
(ke)) of the elimination phase of the concentration-time profile and the
last measured concentration. A slight error in slope and thus ke may
induce an error in calculated clearance. Therefore, an extrapolated
AUCt→inf beneath 20% is globally set as criterion. Chromatograms of
the quantifier and qualifier ions at LOQ (iohexol and PAH) and rLLOQ
(creatinine) level in pig and broiler chicken plasma are presented in
Supplementary Figs. S1 and S2.
In the chromatograms of blank chicken and pig plasma (Fig. 2a and
b) no peaks were observed at the elution zones of iohexol and PAH,
demonstrating no endogenous interference. As expected, a creatinine
peak was observed in the blank plasma.
3.4.4. Analysis of biological samples
The applicability of the method described in this paper was de-
monstrated by analysing broiler chicken and porcine plasma samples.
Samples were collected following an IV bolus injection of iohexol
(64.7 mg/kg), PAH (10mg/kg) and/or creatinine (40mg/kg). An ex-
ample of an LC-MS/MS chromatogram of a porcine sample taken at
15min after IV administration of the three renal markers can be found
in Fig. 2c. Representative plasma concentration-time profiles of one
broiler chicken and one pig can be found in Fig. 3a, b and c. As pre-
sented in the graphs, most of the plasma concentration levels of the
three compounds fell within the concentration range of 0.25–90 μg/mL.
Table 4
Validation results for within-day precision (n=6) and between-day precision (n= 3×3) with corresponding accuracy at LOQ, low, medium and high concentration
for iohexol, para-aminohippuric acid (PAH) and creatinine in porcine and broiler chicken plasma.
Analyte Spiked concentration (μg/mL) Mean concentration ± SD (μg/mL) Precision (RSD, %) Accuracy (%)
Porcine Chicken Porcine Chicken Porcine Chicken
Iohexola 0.25 0.25 ± 0.02 0.26 ± 0.01 7.0 5.8 −0.9 2.0
1 1.02 ± 0.05 0.98 ± 0.07 4.6 6.8 2.0 −2.3
10 10.34 ± 0.40 9.40 ± 0.26 3.9 2.8 3.4 −6.0
75 78.66 ± 3.82 73.40 ± 2.0 4.9 2.7 4.9 −2.1
Iohexolb 0.25 0.25 ± 0.02 0.25 ± 0.02 10.0 8.9 −0.7 −1.9
1 1.05 ± 0.05 0.95 ± 0.10 5.0 10.5 5.2 −4.8
10 9.91 ± 0.46 9.52 ± 0.61 4.7 6.4 −0.8 −4.8
75 75.37 ± 3.19 77.01 ± 3.67 4.2 4.8 0.5 2.7
PAHa 0.25 0.25 ± 0.01 0.27 ± 0.02 4.2 8.6 −1.8 6.9
1 1.00 ± 0.04 1.03 ± 0.09 3.6 8.3 0.3 2.8
10 9.66 ± 0.44 10.67 ± 0.31 4.5 2.9 −3.4 6.7
75 67.69 ± 2.70 68.58 ± 6.79 4.0 9.9 −9.8 −8.6
PAHb 0.25 0.23 ± 0.02 0.25 ± 0.03 8.9 10.5 −9.1 1.9
1 1.07 ± 0.13 0.96 ± 0.08 11.9 8.8 7.1 −4.2
10 10.40 ± 0.82 10.28 ± 0.70 7.9 6.8 4.0 2.8
75 71.54 ± 5.87 74.04 ± 5.56 8.2 7.5 −4.6 −1.3
Creatininea,c 1 –d 1.07 ± 0.09 –d 8.4 –d 7.5
5 4.77 ± 0.29 –e 6.2 –e −4.5 –e
10 9.45 ± 0.48 10.56 ± 0.62 5.1 5.8 −5.5 5.6
75 69.50 ± 1.46 77.08 ± 0.89 2.1 1.2 −7.3 2.8
Creatinineb,c 1 –d 1.04 ± 0.07 –d 6.6 –d 4.0
5 4.71 ± 0.37 –e 7.8 –e −5.8 –e
10 9.07 ± 0.78 10.29 ± 0.82 8.6 8.0 −9.3 2.9
75 72.38 ± 2.23 76.62 ± 3.47 3.1 4.5 −3.5 2.2
a Within-day accuracy and precision.
b Between-day accuracy and precision.
c Quantification using the surrogate calibration curve.
d Failed.
e Not determined; SD: standard deviation; RSD: relative standard deviation; acceptance criteria: accuracy:> 10 ng/mL: −20% to +10%, within-day precision
(RSDmax): ≥ 100 ng/mL: 10.0%, between-day precision: 0.25 μg/mL: 19.7%, 1 μg/mL: 16.0%, 5 μg/mL: 12.6%, 10 μg/mL: 11.3% and 75 μg/mL: 8.4%.
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Samples with analyte concentrations beyond the highest level of the
calibration range were appropriately diluted. As can be seen PAH
plasma concentration was much below than 30 μg/mL, which minimize
the chance on saturation of tubular secretion and improve the estima-
tion of the ERPF. The plasma concentration-time profiles were used to
determine the total body clearances of these renal markers by dividing
the dose by AUC0➔inf. Clearance values for iohexol, which reflect the
GFR, were 3.24 and 2.94mL/kg/min, for pig and broiler chicken re-
spectively. The creatinine clearance, another measure for the GFR, was
3.91mL/kg/min for pig and 8.68mL/kg/min for chicken. For chicken,
the PAH clearance, which is a measure for ERPF, was 117.5mL/kg/
min. A value of 23.64mL/kg/min was obtained for the pig. The values
for creatinine and iohexol clearance were in the same range in the pig,
although slightly higher for creatinine. This is probably attributed to
the fact that besides glomerular filtration, creatinine is to a lesser extent
also secreted in the renal tubules (± 10–20%), as is reported in humans
[47,48]. These results are in contrast to the broiler chicken, where
much higher clearance values were obtained for creatinine in com-
parison to iohexol. Further research is necessary to clarify this differ-
ence.
4. Conclusion
The aim of this study was to develop an LC–MS/MS method for the
simultaneous, quantitative determination of iohexol, PAH and exo-
genously administered creatinine in plasma of pigs and broiler
chickens. Special attention, especially concerning LOQ and accuracy,
was given during the validation of the endogenously present com-
pound, creatinine. Since this method was developed to analyse a large
number of samples for pharmacokinetic studies, a high-throughput
sample analyses and short chromatographic run was preferred. For pig
plasma, a simple deproteinization step was selected as sample pre-
paration method, whereas for chicken plasma a more elaborate sample
preparation with an Ostro™ 96 Well plate was chosen. The use of an
Ostro™ 96 well plate allowed the removal of disturbing phospholipids,
resulting in more purified samples. In spite of the low recovery of PAH
and the presence of matrix effects for creatinine, the validation results
for the different parameters fell within the specified ranges.
Furthermore, chromatographic separation was achieved within a run
time of 10min. The applicability of the presented method was de-
monstrated by the analysis of broiler chicken and porcine PK plasma
samples. In conclusion, a fast, sensitive and specific LC-MS/MS method
for the quantitative determination of iohexol, PAH and creatinine in
chicken broiler and porcine plasma was successfully developed and
validated. In the future, this method can be used to evaluate the renal
function and the effect of divergent (induced)-disease states, like LPS-
induced sepsis, on the excretory renal function.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jchromb.2019.04.017.
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